Essity AB (publ)
STO:ESSITY B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (1.5), the stock would be worth kr259.44 (6% upside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.4 | kr244.5 |
0%
|
| 3-Year Average | 1.5 | kr259.44 |
+6%
|
| 5-Year Average | 1.5 | kr271 |
+11%
|
| Industry Average | 0.8 | kr143.39 |
-41%
|
| Country Average | 2.1 | kr377.4 |
+54%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
kr190.5B
|
/ |
Apr 2026
kr136.7B
|
= |
|
|
kr190.5B
|
/ |
Dec 2026
kr144.2B
|
= |
|
|
kr190.5B
|
/ |
Dec 2027
kr148.4B
|
= |
|
|
kr190.5B
|
/ |
Dec 2028
kr152B
|
= |
|
|
kr190.5B
|
/ |
Dec 2029
kr161.2B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| SE |
|
Essity AB (publ)
STO:ESSITY B
|
167B SEK | 1.4 | 13.4 | |
| US |
|
Procter & Gamble Co
NYSE:PG
|
342.2B USD | 4.2 | 21.2 | |
| US |
|
Colgate-Palmolive Co
NYSE:CL
|
69.9B USD | 3.7 | 32.8 | |
| UK |
|
Reckitt Benckiser Group PLC
LSE:RKT
|
30.7B GBP | 2.7 | 9.7 | |
| US |
|
Kimberly-Clark Corp
NYSE:KMB
|
32.4B USD | 2.3 | 15.3 | |
| DE |
|
Henkel AG & Co KGaA
XETRA:HEN3
|
25.3B EUR | 1.1 | 12.4 | |
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
22.7B USD | 3.9 | 30.8 | |
| US |
|
Clorox Co
NYSE:CLX
|
10.5B USD | 1.9 | 13.9 | |
| JP |
|
Unicharm Corp
TSE:8113
|
1.6T JPY | 1.3 | 24.4 | |
| MX |
|
Kimberly-Clark de Mexico SAB de CV
BMV:KIMBERA
|
116.8B MXN | 2.3 | 15.4 | |
| US |
|
Reynolds Consumer Products Inc
NASDAQ:REYN
|
4.4B USD | 1.6 | 14.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.1 |
| Median | 2.1 |
| 70th Percentile | 5.1 |
| Max | 15 188 |
Other Multiples
Essity AB (publ)
Glance View
Essity AB (publ), a global hygiene and health company headquartered in Stockholm, Sweden, has carved out a pivotal role in improving well-being for millions. Born out of the restructuring of the industrial giant SCA Group in 2017, Essity has grown to become one of the leading players in hygiene and health products. The company focuses its operations in three core areas: personal care, consumer tissue, and professional hygiene. This diversity in product offerings allows Essity to cater to a wide audience, from individual consumers to businesses and healthcare institutions. Essity’s robust revenue model is built on its brand portfolio, featuring well-known names like TENA and Tork, which command significant market share and customer loyalty. Through a well-established network, the company delivers products that range from incontinence aids and baby diapers to tissue paper and professional cleaning solutions. With a strategic emphasis on sustainability and circular economy principles, Essity not only fulfills everyday needs but also aligns with global trends for environmentally responsible business practices. By leveraging advanced research and development, Essity ensures it stays at the forefront of innovation, enhancing both its profitability and its impact on public well-being.